Green Benedict T, Calvin Andrew, O'Grady Scott M, Brown David R
Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul, MN 55105-6010, USA.
J Pharmacol Exp Ther. 2003 May;305(2):733-9. doi: 10.1124/jpet.102.047829. Epub 2003 Feb 11.
The intestinal secretory actions of the proinflammatory peptide kallidin (lysyl-bradykinin) are mediated partially by enteric neurons. We hypothesized that kallidin produces neurogenic anion secretion through opioid- and cannabinoid-sensitive enteric neural pathways. Changes in short-circuit current (I(sc)) across sheets of porcine ileal mucosa-submucosa mounted in Ussing chambers were measured in response to kallidin (1 microM) or drugs added to the contraluminal bathing medium. Kallidin transiently increased I(sc), an effect reduced after inhibition of neuronal conduction by 0.1 microM saxitoxin, cyclooxygenase inhibition by 10 microM indomethacin, or kinin B(2) receptor blockade by 1 microM d-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolylglycyl-3-(2-thienyl)-l-alanyl-l-seryl-d-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-l-(2alpha,3beta,7alphabeta)-octahydro-1H-indole-2-carbonyl-l-arginine (HOE-140). Its action was dependent upon extracellular Cl(-) or HCO(3)(-) ions, but was resistant to 10 microM bumetanide or 0.3 mM 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid, and seemed to involve luminal alkalinization as measured by pH-stat titration. Kallidin-induced I(sc) elevations were sensitive to saxitoxin in tissues bathed in Cl(-)-, but not HCO(3)(-)-deficient media. Tissues pretreated with 0.1 microM [d-Pen(2,5)]-enkephalin, a selective delta-opioid agonist, displayed reduced I(sc) responses to kallidin; this effect was prevented by the delta-opioid antagonist naltrindole. At a contraluminal concentration of 1 microM, the cannabinoid receptor agonist (6aR)-trans-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol (HU-210) also attenuated responses to kallidin. Proinflammatory kinins seem to stimulate neurogenic anion secretion in porcine ileum by activating enteric neural circuits expressing inhibitory opioid and possibly cannabinoid receptors.
促炎肽缓激肽(赖氨酰缓激肽)的肠道分泌作用部分由肠神经元介导。我们推测缓激肽通过对阿片样物质和大麻素敏感的肠神经通路产生神经源性阴离子分泌。在置于Ussing室的猪回肠黏膜 - 黏膜下层薄片上,测量跨膜短路电流(I(sc))的变化,以响应缓激肽(1微摩尔)或添加到对侧管腔浴液中的药物。缓激肽使I(sc)短暂增加,在被0.1微摩尔石房蛤毒素抑制神经元传导、被10微摩尔吲哚美辛抑制环氧化酶或被1微摩尔d - 精氨酰 - l - 精氨酰 - l - 脯氨酰 - 反式 - 4 - 羟基 - l - 脯氨酰甘氨酰 - 3 - (2 - 噻吩基) - l - 丙氨酰 - l - 丝氨酰 - d - 1,2,3,4 - 四氢 - 3 - 异喹啉羰基 - l - (2α,3β,7αβ) - 八氢 - 1H - 吲哚 - 2 - 羰基 - l - 精氨酸(HOE - 140)阻断激肽B(2)受体后,该效应减弱。其作用依赖于细胞外Cl(-)或HCO(3)(-)离子,但对10微摩尔布美他尼或0.3毫摩尔4,4'-二异硫氰酸根合芪 - 2,2'-二磺酸具有抗性,并且通过pH计滴定测量似乎涉及管腔碱化。在Cl(-) - 但不是HCO(3)(-) - 缺乏的培养基中孵育的组织中,缓激肽诱导的I(sc)升高对石房蛤毒素敏感。用0.1微摩尔[d - Pen(2,5)] - 脑啡肽(一种选择性δ - 阿片样物质激动剂)预处理的组织,对缓激肽的I(sc)反应降低;该效应被δ - 阿片样物质拮抗剂纳曲吲哚阻止。在对侧管腔浓度为1微摩尔时,大麻素受体激动剂(6aR) - 反式 - 3 - (1,1 - 二甲基庚基) - 6a,7,10,10a - 四氢 - 1 - 羟基 - 6,6 - 二甲基 - 6H - 二苯并[b,d]吡喃 - 9 - 甲醇(HU - 210)也减弱了对缓激肽的反应。促炎激肽似乎通过激活表达抑制性阿片样物质以及可能的大麻素受体的肠神经回路来刺激猪回肠中的神经源性阴离子分泌。